scholarly journals Enterococcus faecalisSepticemia and Vertebral Osteomyelitis after Transrectal Ultrasound Guided Biopsy of the Prostate

2015 ◽  
Vol 2015 ◽  
pp. 1-3 ◽  
Author(s):  
Ayaz Virji ◽  
Lucio R. Minces ◽  
Zargham Abbass
Keyword(s):  
Escherichia Coli ◽  
Enterococcus Faecalis ◽  
Prostate Biopsy ◽  
Vertebral Osteomyelitis ◽  
Transrectal Ultrasound ◽  
Ultrasound Guided ◽  
Disseminated Infection ◽  
Guided Biopsy ◽  
First Case ◽  
Ultrasound Guided Biopsy

Transrectal ultrasound guided prostate biopsy (TRUS) has rarely been associated with disseminated infection, yet the occurrence appears to be increasing. Resistance to fluoroquinolones, the most commonly used prophylaxis, is one of the likely causes, withEscherichia colibeing the most commonly reported cause of these infections. Herein we present what is, to our knowledge, the first case ofEnterococcus faecalissepticemia and vertebral osteomyelitis after TRUS. Previously reported cases of this condition are referenced also.

Modification of Antimicrobial Prophylaxis Based on Rectal Culture Results to Prevent Fluoroquinolone-Resistant Escherichia coli Infections after Prostate Biopsy

2013 ◽  
Vol 34 (9) ◽  
pp. 973-976 ◽  
Author(s):  
Nuntra Suwantarat ◽  
Donald M. Dumford ◽  
Rafael Ponce-Terashima ◽  
Sirisha Kundrapu ◽  
Trina F. Zabarsky ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Prostate Biopsy ◽  
Antimicrobial Prophylaxis ◽  
Transrectal Ultrasound ◽  
Ultrasound Guided ◽  
Guided Biopsy ◽  
Screening Protocol ◽  
Ultrasound Guided Biopsy

For patients undergoing transrectal ultrasound-guided biopsy of the prostate (TRUBP), use of rectal screening culture results to guide antimicrobial prophylaxis was effective for prevention of fluoro-quinolone-resistant Escherichia coli infections. In practice, elimination of infections after TRUBP required the rectal screening protocol and addition of gentamicin for patients missing prior screening.

scholarly journals Infections caused by fluoroquinolone-resistant Escherichia coli following transrectal ultrasound-guided biopsy of the prostate

2014 ◽  
Vol 2 (2) ◽  
pp. 71-76 ◽  
Author(s):  
Nuntra Suwantarat ◽  
Susan D. Rudin ◽  
Steven H. Marshall ◽  
Andrea M. Hujer ◽  
Federico Perez ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Transrectal Ultrasound ◽  
Ultrasound Guided ◽  
Guided Biopsy ◽  
Ultrasound Guided Biopsy

scholarly journals Ultrasound-guided prostate biopsy: indication, morbidity and outcome at Hopital General Idrissa Pouye

2021 ◽  
Vol 27 (1) ◽  
Author(s):  
Modou Ndiaye ◽  
Mouhamed Jalloh ◽  
Madina Ndoye ◽  
Samba Thiapato Faye ◽  
Saint Charles Nabab Kouka ◽  
...  
Keyword(s):  
Prostate Biopsy ◽  
Statistical Significance ◽  
Transrectal Ultrasound ◽  
Common Finding ◽  
Ultrasound Guided ◽  
Chi Square ◽  
Rectal Examination ◽  
Guided Biopsy ◽  
Total Psa ◽  
Ultrasound Guided Biopsy

Abstract Background Magnetic resonance imaging (MRI)-guided prostate biopsy has a higher sensitivity than the ultrasound-guided biopsy, but its realization requires a dedicated interventional MRI, specific material, which is not available in our context; hence, ultrasound-guided biopsy remains of great interest. Currently, ultrasound-guided biopsy outside of a clinical trial is the gold standard for the diagnosis of prostate cancer. The objective of our work is to evaluate our practice of transrectal ultrasound-guided prostate biopsy using an endorectal probe by describing the technique and evaluating the morbidity and results. Methods This is a descriptive study of ultrasound-guided prostatic biopsies performed over a 2-year period. The parameters studied were frequency of the procedure, age, rectal examination findings, total PSA level, prostate biopsy morbidities and results. Descriptive statistics were performed, and comparison of qualitative variables was made by the Chi-square test with statistical significance set for α < 5% Results Two hundred and thirty-one patients were included over a two-year period. The mean age of our patients was 65 ± 8.2 years. Rectal examination finding was suspicious in 36.9% and the median total PSA was 19.8 ng/ml (0.1-5936 ng/ml). Seventy-seven percent of patients reported their pathology results. Prostatic adenocarcinoma was the most common finding accounting for 53.7% of results. Complications were observed in 16 patients (6.9%) with a predominance of initial hematuria, voiding pain and fever. Conclusion In our series, the cancer detection rate was significant and the complications rate was acceptable at 6.9%.

Outbreak of Fluoroquinolone-Resistant Escherichia coli Infections after Transrectal Ultrasound—Guided Biopsy of the Prostate

2013 ◽  
Vol 34 (3) ◽  
pp. 269-273 ◽  
Author(s):  
Donald Dumford ◽  
Nuntra Suwantarat ◽  
Vineet Bhasker ◽  
Sirisha Kundrapu ◽  
Trina F. Zabarsky ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Medical Center ◽  
Transrectal Ultrasound ◽  
Prediction Rule ◽  
The United States ◽  
Fluoroquinolone Resistance ◽  
Ultrasound Guided ◽  
E Coli ◽  
Guided Biopsy ◽  
Ultrasound Guided Biopsy

Design.We conducted an investigation after identifying a cluster of 4 serious infections following transrectal ultrasound–guided biopsy of the prostate (TRUBP) during a 2-month period.Setting.veterans Affairs medical center.Patients.Patients with urinary tract infection (UTI) after TRUBP and time-matched controls with no evidence of infection.Methods.The incidence of UTI within 30 days after TRUBP was calculated from 2002 through 2010. We evaluated the correlation between infection with fluoroquinolone-resistant gram-negative bacilli (GNB) and fluoroquinolone resistance in outpatient Escherichia coli urinary isolates and performed a case-control study to determine risk factors for infection with fluoroquinolone-resistant GNB. Processes for TRUBP prophylaxis, procedures, and equipment sterilization were reviewed.Results.An outbreak of UTI due to fluoroquinolone-resistant E. coli after TRUBP began 2 years before the cluster was identified and was correlated with increasing fluoroquinolone resistance in outpatient E. coli. No deficiencies were identified in equipment processing or biopsy procedures. Fluoroquinolone-resistant E. coli UTI after TRUBP was independently associated with prior infection with fluoroquinolone-resistant GNB (adjusted odds ratio, 20.8; P = .005). A prediction rule including prior UTI, hospitalization in the past year, and previous infection with fluoroquinolone-resistant GNB identified only 17 (49%) of 35 cases.Conclusions.The outbreak of fluoroquinolone-resistant E. coli infections after TRUBP closely paralleled rising rates of fluoroquinolone resistance among outpatient E. coli isolates. The delayed detection of the outbreak and the absence of sensitive predictors of infection suggest that active surveillance for infection after TRUBP is necessary in the context of increasing fluoroquinolone resistance in the United States.

Sign in / Sign up

Export Citation Format

Share Document